INS and Hyperinsulinemia: Thus, it is tempting to suggest that the hyperinsulinemia and hyperglycemia associated with insulin-resistant conditions, and clinically associated with T2DM, trigger the observed upregulation of GRK2 levels and activities under such conditions.